Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-05 | Mr. Matin has over 20 years of medical technology experience and since July 2018 is Chief Operating Officer of ViewRay, Inc. Mr. Matin has led commercial and technical teams in the United States, Europe and Asia. Previously, he served as Chief Operating Officer of Spectranetics from January 2014 to November 2017. From 2007 – 2014, Mr. Matin held commercial and operation leadership roles of increasing responsibilities at Spectranetics. Before joining Spectranetics, Mr. Matin also served in several commercial and engineering leadership roles at Boston Scientific and Guidant Corporation. Mr. Matin also serves on the board of directors of the Fitzsimons Redevelopment Authority in Aurora, Colorado. He earned a BS in Mechanical Engineering from the University of California, Berkeley, with honors, and an MBA from Harvard Business School. The 2020 FISCAL YEAR DIRECTOR COMPENSATION TABLE does not list Shahriar (Shar) Matin, indicating no compensation for 2020. |
| 2022-03-18 | The following table sets forth the name, age and positions of each Director Nominee: Shahriar (Shar) Matin 47 Director (since May 2021). The 2021 Fiscal Year Director Compensation Table shows Shahriar (Shar) Matin total compensation of $71,133. |
| 2023-03-29 | Shahriar (Shar) Matin CEO, Cordis Corporation Age 48 Committee Membership: CC (Member) Annual Compensation: $110,000 |
| 2024-03-28 | Shahriar (Shar) Matin Cash Retainer $50,000 Common Stock Award $60,000 Total $110,000 Committee Membership: Compensation Committee Member |
| 2025-04-04 | Mr. Matin has over 25 years of medical technology experience and was mostly recently the Chief Executive Officer of Cordis Corporation, a leading cardiovascular medical device company, from 2021 to 2023. Previously, he was the Chief Operating Officer at ViewRay Technologies Inc., an early-stage radiation oncology medical technology firm, from July 2018 to March 2021. Prior to that, he served as Chief Operating Officer of Spectranetics from January 2014 until its sale to Royal Philips in November 2017. From 2007 – 2014, Mr. Matin held commercial and operation leadership roles of increasing responsibilities at Spectranetics. Mr. Matin started his career in several commercial and engineering leadership roles at Boston Scientific and Guidant Corporation. He earned a BS in Mechanical Engineering from the University of California, Berkeley, with honors, and an MBA from Harvard Business School. |
Data sourced from SEC filings. Last updated: 2025-08-30